Lipiodol avidity of neuroendocrine liver metastases.


AIMS Lipiodol has been shown to concentrate in most hepatocellular carcinomas as well as in some liver metastases, including those of neuroendocrine origin. Our aim was to determine the proportion of neuroendocrine liver metastases that take up lipiodol and to identify tumour characteristics that predict avidity. METHODS Avidity was assessed in 12… (More)


Cite this paper

@article{Hewitt1998LipiodolAO, title={Lipiodol avidity of neuroendocrine liver metastases.}, author={Peter Macdonald Hewitt and Derek W Glenn and J. K. Seifert and D. Llewlyn Morris}, journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology}, year={1998}, volume={24 6}, pages={558-61} }